Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Newer antihypertensive agents

G S Thind

    Comprehensive Therapy
    |March 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    New antihypertensive drugs, particularly angiotensin-renin blockers and sodium-volume axis agents, show promise for effective hypertension management. These advancements may lead to better monotherapy options and improved outcomes in renovascular hypertension surgery.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Subcutaneous bupivacaine for postoperative analgesia after herniorrhaphy.

    Annals of the Royal College of Surgeons of England·2009
    Same author

    How invasive should one be?

    Anaesthesia·2001
    Same author

    Local anaesthesia for eye surgery-no room for complacency.

    British journal of anaesthesia·2001
    Same author

    Inadequate pre-operative evaluation and preparation 2.

    Anaesthesia·2001
    Same author

    Airway management/failed intubation drill.

    Anaesthesia·2001
    Same author

    Cadmium-induced arteriolar constriction in skeletal muscle microcirculation.

    American journal of hypertension·1993

    Area of Science:

    • Clinical pharmacology
    • Cardiovascular medicine
    • Hypertension research

    Background:

    • Hypertension is a major focus in clinical pharmacology with significant ongoing research.
    • Numerous novel antihypertensive medications are under development globally.

    Purpose of the Study:

    • To review emerging classes of antihypertensive drugs.
    • To discuss the potential of new agents for monotherapy and improved treatment regimens.
    • To explore the role of angiotensin blockers in renovascular hypertension surgery.

    Main Methods:

    • Review of current research and drug development in hypertension.
    • Analysis of promising drug classes, including angiotensin-renin blockers and sodium-volume axis agents.
    • Evaluation of potential therapeutic applications and surgical adjunctive roles.

    Related Experiment Videos

    Main Results:

    • The most promising new antihypertensive drugs target the angiotensin-renin system or the sodium-volume axis.
    • Future agents are expected to be effective as monotherapy with convenient daily or twice-daily dosing.
    • Angiotensin blockers may enhance the predictability of successful renal bypass surgery in renovascular hypertension.

    Conclusions:

    • Significant advancements are anticipated in antihypertensive pharmacotherapy.
    • Newer drugs offer hope for more effective and convenient hypertension management.
    • Targeted drug use, such as angiotensin blockers, may improve surgical outcomes in specific hypertensive conditions.